Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Activating mutations in the pore-forming Kir6.2 (KCNJ11) and regulatory sulphonylurea receptor SUR1 (ABCC8) subunits of the K(ATP) channel are a common cause of transient neonatal diabetes mellitus (TNDM). We identified a new TNDM mutation (R826W) in the first nucleotide-binding domain (NBD1) of SUR1. The mutation was found in a region that heterodimerizes with NBD2 to form catalytic site 2. Functional analysis showed that this mutation decreases MgATP hydrolysis by purified maltose-binding protein MBP-NBD1 fusion proteins. Inhibition of ATP hydrolysis by MgADP or BeF was not changed. The results indicate that the ATPase cycle lingers in the post-hydrolytic MgADP.P(i)-bound state, which is associated with channel activation. The extent of MgADP-dependent activation of K(ATP) channel activity was unaffected by the R826W mutation, but the time course of deactivation was slowed. Channel inhibition by MgATP was reduced, leading to an increase in resting whole-cell currents. In pancreatic beta cells, this would lead to less insulin secretion and thereby diabetes.

Original publication




Journal article



Publication Date





648 - 654


ATP-Binding Cassette Transporters, Adenosine Diphosphate, Adenosine Triphosphatases, Adenosine Triphosphate, Amino Acid Sequence, Amino Acid Substitution, Arginine, Child, Diabetes Mellitus, Humans, Infant, Newborn, Infant, Newborn, Diseases, Ion Channel Gating, Kinetics, Male, Molecular Sequence Data, Mutant Proteins, Mutation, Potassium Channels, Inwardly Rectifying, Protein Structure, Secondary, Protein Structure, Tertiary, Receptors, Drug, Sulfonylurea Receptors, Tryptophan